Most Recent
‘Hope to see you after you settle’: Sydney light rail class action sent to mediation
A long-running class action over the construction of the Sydney light rail that was revived by the High Court is heading to mediation, with a judge noting the challenges that lie ahead in determining all the claims of group members if the parties don't settle.
Construction PRO
Dexus GC denies being ‘careless’ with APAC info, points to junior lawyer
A senior in-house lawyer at Dexus has rejected suggestions she was “careless” in her role in the sale of shares in Melbourne Airport operator APAC, saying she relied on a subordinate lawyer and others within the business. 
Construction PRO
Dexus execs relied on Mallesons, GC advice over airport share sale, court told
Lawyers assured two Dexus executives that it was OK to share the confidential information of Melbourne Airport operator APAC with proposed purchasers of the real estate asset manager's stake in the company, a court has heard.
‘No sex’ and other rules make Uber an employer, court told
Uber drivers seeking to challenge their classification as independent contractors have argued the rideshare giant had “highly prescriptive” rules on how to behave towards customers, including 'no touching' and 'no sex' rules. 
High Court revives Sydney light rail class action against Transport for NSW
The High Court has revived a class action by small business owners over the interference caused by the construction of the Sydney light rail network.
Construction PRO
Sydney light rail class action revived by High Court
The High Court has revived a class action by small business owners over the interference caused by the construction of the Sydney light rail network.
Ex-Deloitte partner replaced for aspects of Mosaic liquidation
Special purpose liquidators have been appointed to failed clothing retailer Mosaic Brands, after a judge found a reasonable apprehension of bias arising from liquidator Vaughan Strawbridge's former link to Deloitte.
Takeovers Panel says Cosette can’t shutter Mayne’s Adelaide drug plant
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
Mayne wins extension of FIRB deadline for Cosette takeover
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.
Mayne, Cosette row to be decided on merits after panel resets merger clock
The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.